BRVE Stock Chart & Stats
$26.95
--
Market closed
$26.95
--
Day’s Range― - ―
52-Week Range$24.31 - $32.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)444.29K
Market Cap
$2.63B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-2.86
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding90,038,970
10 Day Avg. Volume312,711
30 Day Avg. Volume444,286
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$45.25Price Target Upside67.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Braveheart Bio, Inc. News
BRVE FAQ
What was Braveheart Bio, Inc.’s price range in the past 12 months?
Braveheart Bio, Inc. lowest stock price was $24.30 and its highest was $32.00 in the past 12 months.
What is Braveheart Bio, Inc.’s market cap?
Braveheart Bio, Inc.’s market cap is $2.63B.
When is Braveheart Bio, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Braveheart Bio, Inc.’s earnings last quarter?
Currently, no data Available
Is Braveheart Bio, Inc. overvalued?
According to Wall Street analysts Braveheart Bio, Inc.’s price is currently Undervalued.
Does Braveheart Bio, Inc. pay dividends?
Braveheart Bio, Inc. does not currently pay dividends.
What is Braveheart Bio, Inc.’s EPS estimate?
Braveheart Bio, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Braveheart Bio, Inc. have?
Braveheart Bio, Inc. has 90,038,970 shares outstanding.
What happened to Braveheart Bio, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Braveheart Bio, Inc.?
Currently, no hedge funds are holding shares in BRVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Braveheart Bio, Inc. Stock Smart Score
Company Description
Braveheart Bio, Inc.
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
BRVE Stock 12 Month Forecast
Average Price Target
$45.25
▲(67.90% Upside)